- Home
- FIEE vs EDSA Comparison
FIEE vs EDSA Comparison
Compare FIEE & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIEE
- EDSA
- Stock Information
- Founded
- FIEE N/A
- EDSA 2015
- Country
- FIEE United States
- EDSA Canada
- Employees
- FIEE 43
- EDSA N/A
- Industry
- FIEE Telecommunications Equipment
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- FIEE Utilities
- EDSA Health Care
- Exchange
- FIEE Nasdaq
- EDSA Nasdaq
- Market Cap
- FIEE 17.6M
- EDSA 17.5M
- IPO Year
- FIEE N/A
- EDSA N/A
- Fundamental
- Price
- FIEE $2.71
- EDSA $2.88
- Analyst Decision
- FIEE
- EDSA Strong Buy
- Analyst Count
- FIEE 0
- EDSA 2
- Target Price
- FIEE N/A
- EDSA $13.00
- AVG Volume (30 Days)
- FIEE N/A
- EDSA 110.6K
- Earning Date
- FIEE N/A
- EDSA 08-08-2025
- Dividend Yield
- FIEE N/A
- EDSA N/A
- EPS Growth
- FIEE N/A
- EDSA N/A
- EPS
- FIEE N/A
- EDSA N/A
- Revenue
- FIEE N/A
- EDSA N/A
- Revenue This Year
- FIEE N/A
- EDSA N/A
- Revenue Next Year
- FIEE N/A
- EDSA N/A
- P/E Ratio
- FIEE N/A
- EDSA N/A
- Revenue Growth
- FIEE N/A
- EDSA N/A
- 52 Week Low
- FIEE N/A
- EDSA $1.55
- 52 Week High
- FIEE N/A
- EDSA $4.49
- Technical
- Relative Strength Index (RSI)
- FIEE 45.00
- EDSA 67.27
- Support Level
- FIEE $2.66
- EDSA $2.30
- Resistance Level
- FIEE $2.83
- EDSA $2.82
- Average True Range (ATR)
- FIEE 0.14
- EDSA 0.17
- MACD
- FIEE -0.00
- EDSA 0.03
- Stochastic Oscillator
- FIEE 59.30
- EDSA 100.00
About FIEE FiEE Inc Common Stock
FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.